World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
77
Citations
19301
World Ranking
4827
National Ranking
90

Overview

Achim Weber is affiliated with the University of Zurich in Switzerland and has a research portfolio concentrated primarily within the field of Medicine, with a significant focus on Hepatology. Their scholarly output spans various subfields including Epidemiology, Surgery, Molecular Biology, and Oncology, reflecting a multidisciplinary approach to medical research.

Their main areas of research topics include:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Liver Diseases and Immunity
  • Hepatitis B Virus Studies
  • Hepatitis Viruses Studies and Epidemiology
  • Parasitic infections in humans and animals
  • Cancer Genomics and Diagnostics

Achim Weber has published extensively, with frequent contributions to the Journal of Hepatology, Cancer Cell, Histopathology, bioRxiv (Cold Spring Harbor Laboratory), and Nature Medicine. These venues indicate a strong presence in both clinical and experimental research arenas related to liver diseases and cancer biology.

Some of their recent papers include:

  • "NASH limits anti-tumour surveillance in immunotherapy-treated HCC" (2021, Nature)
  • "Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations" (2021, Cancer Cell)
  • "An integrated perfusion machine preserves injured human livers for 1 week" (2020, Nature Biotechnology)
  • "Enteric Nervous System-Derived IL-18 Orchestrates Mucosal Barrier Immunity" (2020, Cell)
  • "XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis" (2021, Nature Medicine)

Collaborative work forms a substantial part of their research. Frequent co-authors include Mathias Heikenwälder, Daniela Lenggenhager, Beat Müllhaupt, Pierre-Alain Clavien, and Marc E. Healy, who have co-published multiple articles alongside Achim Weber.

Best Publications

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Pfister;Dominik Pfister;Nicolás Gonzalo Núñez;Roser Pinyol;Olivier Govaere

  • NAFLD causes selective CD4 + T lymphocyte loss and promotes hepatocarcinogenesis

    Chi Ma;Aparna H. Kesarwala;Tobias Eggert;José Medina-Echeverz

  • Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes

    Monika Julia Wolf;Arlind Adili;Kira Piotrowitz;Zeinab Abdullah

  • Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.

    Torsten Hansen;Martin Kunkel;Achim Weber;C. James Kirkpatrick

  • Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma

    Marta Garnelo;Alex Tan;Zhisheng Her;Joe Yeong;Joe Yeong

  • A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma

    Johannes Haybaeck;Nicolas Zeller;Monika Julia Wolf;Achim Weber

  • Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma

    Shlomi Finkin;Detian Yuan;Ilan Stein;Koji Taniguchi

  • Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma

    Valerie Chew;Jinmiao Chen;Deming Lee;Evelyn Loh

  • An integrated perfusion machine preserves injured human livers for 1 week.

    Dilmurodjon Eshmuminov;Dustin Becker;Dustin Becker;Lucia Bautista Borrego;Max Hefti;Max Hefti

  • Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation

    Katharina M. Jeltsch;Desheng Hu;Sven Brenner;Jessica Zöller

  • Intratumor Heterogeneity in Hepatocellular Carcinoma

    Juliane Friemel;Markus Rechsteiner;Lukas Frick;Friederike Böhm

  • Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

    Mohsen Malehmir;Dominik Pfister;Suchira Gallage;Marta Szydlowska

  • Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway

    Monika Julia Wolf;Alexandra Hoos;Judith Bauer;Steffen Boettcher

  • TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer.

    Kira Bettermann;Mihael Vucur;Johannes Haybaeck;Christiane Koppe

  • Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.

    Silvia Affo;Ajay Nair;Francesco Brundu;Aashreya Ravichandra

  • Actinomycosis of the jaws—histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis

    Torsten Hansen;Martin Kunkel;Erik Springer;Christian Walter

  • Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head

    Stefan Heinrich;Bernhard C. Pestalozzi;Markus Schäfer;Achim Weber

  • Further clinical and molecular delineation of the 9q Subtelomeric Deletion Syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype

    T Kleefstra;W A van Zelst-Stams;W M Nillesen;V Cormier-Daire

  • Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis.

    Dirk Heitzmann;Renaud Derand;Stefan Jungbauer;Sascha Bandulik

  • Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial.

    Stefan Heinrich;Markus Schäfer;Achim Weber;Thomas F. Hany

Frequent Co-Authors

Mathias Heikenwalder
Mathias Heikenwalder German Cancer Research Center
Gerhard Rogler
Gerhard Rogler University of Zurich
Pierre-Alain Clavien
Pierre-Alain Clavien University of Zurich
Lars Zender
Lars Zender German Cancer Research Center
Holger Moch
Holger Moch University of Zurich
Michael Fried
Michael Fried University of Zurich
Josep M. Llovet
Josep M. Llovet University of Barcelona
Marco Prinz
Marco Prinz University of Freiburg
Percy A. Knolle
Percy A. Knolle Technical University of Munich
Dirk Haller
Dirk Haller Technical University of Munich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As the fields of Biology and Biochemistry continue to diversify, students and professionals are increasingly exploring flexible education options. Online programs offer a convenient way to gain specialized knowledge and certifications that can enhance your career prospects without disrupting your schedule.

For those interested in pharmaceuticals, online pharm d programs provide an accessible route to advanced roles in pharmacy, blending foundational science with practical, patient-focused learning. If you’re passionate about human movement or sports science, an online exercise physiology degree or kinesiology online programs can open doors in fitness, rehabilitation, and research.

Mental health is another growing area in healthcare. Those aiming for a fast-track credential can consider a 1 year pmhnp program online to become a Psychiatric-Mental Health Nurse Practitioner. These pathways highlight the evolving opportunities for biology and biochemistry students to broaden their skills and impact in the science and healthcare sectors.

Best Scientists Citing Achim Weber

Trending Scientists

Recently Published Articles